Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/28/2025

Management of Post-Viral Irritant Cough

  • The American College of Chest Physicians (ACCP) recommends inhaled ipratropium bromide as the initial therapy for post-viral cough, as it has been shown to attenuate post-infectious cough in controlled trials 1, 2, 3
  • The ACCP suggests inhaled corticosteroids as a second-line treatment when cough adversely affects quality of life and persists despite ipratropium use 1, 2, 3
  • The ACCP recommends oral prednisone 30-40 mg daily for a short, finite period as a third-line treatment when other common causes have been ruled out 1, 2, 3
  • Central-acting antitussives, such as codeine or dextromethorphan, may be considered as a last resort when other measures fail 2, 3

Established Clinical Applications for NAC

  • NAC is recommended for COPD exacerbation prevention in patients with moderate-to-severe disease and ≥2 exacerbations in the previous 2 years (600 mg twice daily) 5
  • NAC may be considered for chronic bronchitis with mucus hypersecretion 4, 6

Important Clinical Caveats

  • The ACCP states that antibiotics have no role in treating post-viral cough, as the cause is not bacterial infection 1, 2, 3
  • If cough persists beyond 8 weeks, consider diagnoses other than post-infectious cough, including upper airway cough syndrome, asthma, or gastroesophageal reflux disease 1, 2
  • Consider pertussis when cough lasts >2 weeks with paroxysms, post-tussive vomiting, or inspiratory whooping, and obtain nasopharyngeal culture for definitive diagnosis 2